Clinical Trials in Italy

Active recruiting clinical trials with sites in Italy. Select a condition below to see detailed trial listings.

Total Trials: 481 // Recruiting: 481 // Updated: Daily

Italy currently has 481 clinical trials with at least one registered site in the country, of which 481 are actively recruiting participants. The most studied conditions at Italy sites are Breast Cancer, Heart Failure, Prostate Cancer, reflecting where local investigators and sponsors are concentrating enrolment.

Studies are led by sponsors including Fondazione Policlinico Universitario Agostino Gemelli IRCCS, IRCCS Azienda Ospedaliero-Universitaria di Bologna, IRCCS San Raffaele. By stage, active Italy trials break down as Phase 1 (7), Phase 2 (27), Phase 3 (17), Phase 4 (10). All figures update daily from ClinicalTrials.gov — select a condition below for full listings, eligibility and site contacts.

Top Conditions in Italy

Breast Cancer 10 Heart Failure 9 Prostate Cancer 8 Parkinson Disease 8 Lung Cancer 6 Ovarian Cancer 5 Colorectal Cancer 5 Multiple Sclerosis 5 Stroke 4 Cancer 4 Cardiovascular Diseases 4 Coronary Artery Disease 4 Bladder Cancer 4 Alzheimer Disease 4 NAFLD 3 Heart Transplantation 3 Congenital Hypothyroidism 3 Gynecologic Cancer 3 Pregnancy Complications 3 Atrial Fibrillation 3

All Countries → All Trials →

Other Countries in This Region

🇬🇷Greece 🇩🇪Germany 🇫🇷France 🇪🇸Spain 🇬🇧United Kingdom 🇳🇱Netherlands 🇧🇪Belgium 🇵🇱Poland 🇸🇪Sweden 🇦🇹Austria

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology